UnitedHealth Group (NYSE:UNH) Price Target Raised to $409.00

Key Points

• Jefferies Financial Group has raised its price target for UnitedHealth Group from $317.00 to $409.00, indicating a potential upside of 14.45% from the stock's previous close.
• Other analysts have also increased their price targets, with Bank of America setting a target of $390.00 and Goldman Sachs at $406.00, while the consensus rating for the stock is currently "Hold."
• UnitedHealth Group reported earnings of $4.08 per share, missing expectations, and has set a FY 2025 EPS guidance of 16.000.

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target upped by analysts at Jefferies Financial Group from $317.00 to $409.00 in a research report issued on Friday,Benzinga reports. The firm presently has a "buy" rating on the healthcare conglomerate's stock. Jefferies Financial Group's target price points to a potential upside of 14.45% from the stock's previous close.

A number of other analysts have also recently commented on the company. Bank of America upped their price target on UnitedHealth Group from $350.00 to $390.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 8th. The Goldman Sachs Group assumed coverage on UnitedHealth Group in a research report on Tuesday. They issued a "buy" rating and a $406.00 price target for the company. Wells Fargo & Company upped their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 7th. Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Finally, UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $385.13.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $0.70 during trading hours on Friday, reaching $357.37. The company had a trading volume of 7,067,579 shares, compared to its average volume of 12,563,620. UnitedHealth Group has a one year low of $234.60 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business has a fifty day simple moving average of $327.27 and a 200 day simple moving average of $346.01. The firm has a market cap of $323.66 billion, a PE ratio of 15.50, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter last year, the company posted $6.80 EPS. The firm's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Nabity Jensen Investment Management Inc lifted its stake in shares of UnitedHealth Group by 0.9% during the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate's stock worth $1,446,000 after purchasing an additional 24 shares in the last quarter. Atlantic Edge Private Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate's stock worth $160,000 after acquiring an additional 25 shares in the last quarter. Osborne Partners Capital Management LLC lifted its stake in shares of UnitedHealth Group by 2.5% in the first quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate's stock worth $558,000 after acquiring an additional 26 shares in the last quarter. HHM Wealth Advisors LLC raised its stake in UnitedHealth Group by 0.9% during the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate's stock valued at $1,544,000 after buying an additional 26 shares in the last quarter. Finally, MPS Loria Financial Planners LLC raised its stake in UnitedHealth Group by 0.4% during the first quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate's stock valued at $3,800,000 after buying an additional 27 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.